Founder · CEO & Chairman
J. Todd Bonner
More than 30 years across insurance, technology and finance in Asia, including leadership and company-building experience in insurance businesses.
About NextShield
Built at the intersection of insurance, AI and health.
NextShield is developing a practical insurance infrastructure platform that connects administration, decision-support technology and risk analytics across Asian markets.
Our belief
Smarter insurance starts with better infrastructure.
We believe risk decisions should be more informed, explainable and operationally useful. That requires more than an algorithm: it requires experienced people, controlled data, workable processes and responsible partners.
NextShield is not positioned as a traditional insurer or reinsurer. We provide AI-driven insurance infrastructure and administration capabilities, and may support risk-sharing structures only through appropriately licensed, authorised and contracted entities.
Leadership
Experience across insurance, AI, health and technology.
Founder · CTO
Dr. Hui-Yi Fan
AI specialist with experience advising research, policy and innovation organisations, and leading applied AI initiatives.
Chief Scientist
Dr. Shiu-Ming Huang
Health and welfare policy specialist with academic and applied experience across healthcare systems and population health.
Director
Albert Wu
More than 25 years in computing and telecommunications, including senior regional and global operating roles.
Director
Steven
Member of the NextShield leadership team.
Director
Benny Phang
Member of the NextShield leadership team.
Director
Patrick Wang
Member of the NextShield leadership team.
Team foundation
Backed by a multidisciplinary operating and advisory network.
22person core team reflected in the business materials
9medical and biostatistics advisers
Operating approach
Technology in Taipei. Operations in Singapore.
NextShield combines AI development, insurance experience, health expertise and cross-border execution. Our operating hubs are Singapore and Taipei, with market activity supported through local partners.
- Insurance and program operations
- AI and data engineering
- Medical and biostatistics guidance
- Cross-border structuring and implementation
Selected advisers
Medical and biostatistics expertise.
The underlying materials identify advisers with senior academic, clinical and public-health experience. Engagement and availability may vary by project.
Dr. Ching-Yuang LinImmunology · Osaka University
Dr. Chao-Sung ChangMedical Science · Kaohsiung Medical University
Dr. Yaoh-Shiang LinMedicine · National Defense Medical Center
Dr. Nain-Feng ChuPublic Health · Harvard University
Dr. Tzay-Jinn ChenHealthcare Management · Harvard University
Dr. Tung-Liang ChiangHealth Policy and Management · Johns Hopkins University
Dr. Shou-Hsia ChengHealth Policy · Yale School of Medicine
Dr. Chung-Fu LanHealthcare and Hospital Administration · Johns Hopkins University
Dr. Shiao-Chi WuPublic Health · National Taiwan University
How we work
Practical, explainable and partner-led.
Practical
Technology must fit real workflows, roles, data and service obligations.
Explainable
Decision-support outputs should be understandable and reviewable by responsible professionals.
Responsible
Regulated activities, data access and risk transfer require the right governance and authorised partners.
Work with a cross-functional insurance infrastructure team.
Tell us which operating, underwriting or risk problem you are trying to solve.